Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer
Clinical trial NCT06413745 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06413745
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2026-12-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.